Doximity reported third-quarter fiscal 2025 results that beat analysts' expectations for revenue and guidance. The company's revenue increased 25% to $168.6 million in its third quarter. Doximity ...

Doximity (NYSE:DOCS) delivers a strong report, with guidance that points to an attractive increase in profitability. On top of that, Doximity holds no debt and has ample cash on its balance sheet, ...

US News & World Report has teamed up with Doximity, a social network for doctors, to develop a new tool that lets patients book appointments while they are looking at doctors’ profiles on USNews.com. ...

BofA analyst Allen Lutz raised the firm’s price target on Doximity (DOCS) to $57 from $54 and keeps a Neutral rating on the shares. The firm believes that Doximity should trade at a premium to ...

Doximity Inc. company and executive profile by Barron's. View the latest DOCS company infomation and executive bios.

Doximity is a rare IT vendor who reported positive business trends when it released its Q3 results at the start of November, 2022. The company's big pharma and hospital customers showed increased ...

Doximity, a digital platform for medical professionals, cut its workforce by 10%, or 100 employee positions, and downgraded its revenue guidance as it faces economic pressures and slowing sales among ...

Forbes contributors publish independent expert analyses and insights. I write about the intersection of health care, technology and policy Feb 26, 2025, 08:00am EST Feb 26, 2025, 09:22am EST Last ...